Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape

Autor: Hawes, I.A., Alvarenga, B.D., Browne, W., Wapniarski, A., Dandekar, R., Bartley, C.M., Sowa, G.M., DeRisi, J.L., Cinque, P., Dravid, A.N., Pleasure, S.J., Gisslen, M., Price, R.W., Wilson, M.R.

Publikováno v: In Journal of Neuroimmunology 15 August 2023 381

Antigen-Specific T Cell Receptor Discovery for Treating Progressive Multifocal Leukoencephalopathy.

Autor: Gupta S; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Martinov T; Fred Hutchinson Cancer Center and University of Washington, Seattle WA., Thelen A; Fred Hutchinson Cancer Center and University of Washington, Seattle WA., Sunahara M; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Mureli S; Fred Hutchinson Cancer Center and University of Washington, Seattle WA., Vazquez A; Fred Hutchinson Cancer Center and University of Washington, Seattle WA., Gerdts J; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Dandekar R; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Cortese I; Experimental Immunotherapeutics Unit, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD., Fouassier C; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA., Schanzer E; Department of Molecular and Cell Biology, University of California, Berkeley.; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA., Urnov FD; Department of Molecular and Cell Biology, University of California, Berkeley.; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA., Marson A; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA.; Gladstone-UCSF Institute of Genomic Immunology, University of California San Francisco, San Francisco CA., Shy BR; Gladstone-UCSF Institute of Genomic Immunology, University of California San Francisco, San Francisco CA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA., Greenberg PD; Fred Hutchinson Cancer Center and University of Washington, Seattle WA., Wilson MR; Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.

An autoantibody signature predictive for multiple sclerosis.

Autor: Zamecnik CR; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Sowa GM; University of California, San Francisco School of Medicine, San Francisco, CA, USA.; Department of Medicine, McGaw Medical Center of Northwestern University, Chicago, IL, USA., Abdelhak A; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Dandekar R; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Bair RD; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Wade KJ; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Bartley CM; Department of Psychiatry and Behavioral Sciences, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Kizer K; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Augusto DG; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC, USA., Tubati A; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Gomez R; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Fouassier C; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Gerungan C; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Caspar CM; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Alexander J; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Wapniarski AE; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Loudermilk RP; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Eggers EL; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Zorn KC; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA., Ananth K; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Jabassini N; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Mann SA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA, USA., Ragan NR; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Santaniello A; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Henry RG; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Baranzini SE; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Zamvil SS; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Sabatino JJ Jr; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Bove RM; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Guo CY; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Gelfand JM; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Cuneo R; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., von Büdingen HC; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Oksenberg JR; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Cree BAC; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Hollenbach JA; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA., Green AJ; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Hauser SL; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Wallin MT; Department of Veterans Affairs, Multiple Sclerosis Center of Excellence, Washington, DC, USA.; University of Maryland School of Medicine, Baltimore, MD, USA., DeRisi JL; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA, USA., Wilson MR; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. michael.wilson@ucsf.edu.

Publikováno v: Nature medicine [Nat Med] 2024 May; Vol. 30 (5), pp. 1300-1308. Date of Electronic Publication: 2024 Apr 19.

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.

Autor: Ozonoff A; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Jayavelu ND; Benaroya Research Institute, Seattle, WA, USA., Liu S; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Melamed E; The University of Texas at Austin, Austin, TX, USA., Milliren CE; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Qi J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Geng LN; Stanford University, Stanford, CA, USA., McComsey GA; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH, USA., Cairns CB; Drexel University/Tower Health Hospital, Philadelphia, PA, USA., Baden LR; Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Schaenman J; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA., Shaw AC; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Samaha H; Emory University, Atlanta, GA, USA., Seyfert-Margolis V; MyOwnMed, Inc, Bethesda, MD, USA., Krammer F; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rosen LB; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA., Steen H; Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Syphurs C; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Dandekar R; University of California San Francisco School of Medicine, San Francisco, CA, USA., Shannon CP; Centre for Heart Lung Innovation, Providence Research, St. Paul's Hospital, and the PROOF Centre of Excellence, Vancouver, BC, Canada., Sekaly RP; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH, USA., Ehrlich LIR; The University of Texas at Austin, Austin, TX, USA., Corry DB; Baylor College of Medicine, and the Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, USA., Kheradmand F; Baylor College of Medicine, and the Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, USA., Atkinson MA; University of Florida/University of South Florida, Tampa, FL, USA., Brakenridge SC; University of Florida/University of South Florida, Tampa, FL, USA., Higuita NIA; Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Metcalf JP; Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Hough CL; Oregon Health & Science University, Portland, OR, USA., Messer WB; Oregon Health & Science University, Portland, OR, USA., Pulendran B; Stanford University, Stanford, CA, USA., Nadeau KC; Stanford University, Stanford, CA, USA., Davis MM; Stanford University, Stanford, CA, USA., Sesma AF; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Simon V; Icahn School of Medicine at Mount Sinai, New York, NY, USA., van Bakel H; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kim-Schulze S; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Hafler DA; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Levy O; Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Kraft M; University of Arizona, Tucson, AZ, USA., Bime C; University of Arizona, Tucson, AZ, USA., Haddad EK; Drexel University/Tower Health Hospital, Philadelphia, PA, USA., Calfee CS; University of California San Francisco School of Medicine, San Francisco, CA, USA., Erle DJ; University of California San Francisco School of Medicine, San Francisco, CA, USA., Langelier CR; University of California San Francisco School of Medicine, San Francisco, CA, USA., Eckalbar W; University of California San Francisco School of Medicine, San Francisco, CA, USA., Bosinger SE; Emory University, Atlanta, GA, USA., Peters B; La Jolla Institute for Immunology, La Jolla, CA, USA., Kleinstein SH; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Reed EF; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA., Augustine AD; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA., Diray-Arce J; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Maecker HT; Stanford University, Stanford, CA, USA., Altman MC; Benaroya Research Institute, Seattle, WA, USA., Montgomery RR; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Becker PM; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA., Rouphael N; Emory University, Atlanta, GA, USA. nroupha@emory.edu.

Publikováno v: Nature communications [Nat Commun] 2024 Jan 03; Vol. 15 (1), pp. 216. Date of Electronic Publication: 2024 Jan 03.

Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.

Autor: Bartley CM; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA., Ngo TT; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Do LD; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon and SynatAc Team, Institut Mechanisms in Integrated Life Sciences, L'Institut national de la santé et de la recherche médicale, U1314/CNRS UMR 5284, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Zekeridou A; Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Dandekar R; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Muñiz-Castrillo S; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon and SynatAc Team, Institut Mechanisms in Integrated Life Sciences, L'Institut national de la santé et de la recherche médicale, U1314/CNRS UMR 5284, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Alvarenga BD; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Zorn KC; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA., Tubati A; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Pinto AL; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon and SynatAc Team, Institut Mechanisms in Integrated Life Sciences, L'Institut national de la santé et de la recherche médicale, U1314/CNRS UMR 5284, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Browne WD; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Hullett PW; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Terrelonge M; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Schubert RD; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Piquet AL; Department of Neurology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA., Yang B; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Montalvo M; Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Kung AF; PhD Degree Program in Biological and Medical Informatics, School of Medicine, University of California, San Francisco, San Francisco, CA, USA., Mann SA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Shah MP; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Geschwind MD; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Gelfand JM; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., DeRisi JL; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA., Pittock SJ; Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Honnorat J; French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon and SynatAc Team, Institut Mechanisms in Integrated Life Sciences, L'Institut national de la santé et de la recherche médicale, U1314/CNRS UMR 5284, Universités de Lyon, Université Claude Bernard Lyon 1, Lyon, France., Pleasure SJ; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA., Wilson MR; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

Publikováno v: Annals of neurology [Ann Neurol] 2023 Dec; Vol. 94 (6), pp. 1086-1101. Date of Electronic Publication: 2023 Sep 19.